Immunological markers of rheumatoid arthritis

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Rheumatoid arthritis (RA) is the most common connective tissue disease of autoimmune origin. The disease is characterized by chronic inflammation leading to bone erosions and organ involvement. RA is a progressive disease. It affects the quality of life, leading to disability and death mainly due to premature cardiovascular disease. Early diagnosis and appropriate treatment are essential for prognosis and quality of life improvement.In 2010 the American College of Rheumatology (ACR) and The European League Against Rheumatism (EULAR) established new RA classification criteria. Besides clinical symptoms it includes two immunologic criteria: rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP antibodies). RF is the first well-known RA immunologic marker. It is observed in 80-85% of patients with RA. Elevated serum level of RF has been associated with increased disease activity, radiographic progression, and the presence of extraarticular manifestations. The sensitivity of RF is 50-90%, and specificity is 50-95%. Anti-CCP antibodies appear to be a more specific marker than RF. They are often present at the very beginning of the disease, or even years before the first symptoms. The prognostic value of anti-CCP antibodies is well established. High serum level of anti-CCP correlates with poor prognosis and early erosions of the joints. The sensitivity of anti-CCP2 is 48-80%, and specificity is 96-98%.New immunologic markers include anti-carbamylated protein antibodies (anti-CarP) and antibodies against heterogeneous nuclear ribonucleoproteins (anti-hnRNP A2/B1, RA33). Scientists aim to identify a highly sensitive and specific biomarker of the disease that not only has diagnostic and prognostic value but also may predict the response to treatment.

Authors and Affiliations

Agnieszka Matuszewska, Marta Madej, Piotr Wiland

Keywords

Related Articles

Searching for Tourette’s syndrome gene. Part 2. Patient’s genome variability

Gilles de la Tourette syndrome (GTS) is a complex, heterozygous genetic disorder. Twenty chromosomal rearrangements (7q22-q31, 8q13-q22, and 18q22) indicating genomic regions which may be involved in the etiology of the...

Breast cancer metastasis – insight into selected molecular mechanisms of the phenomenon

Metastasis is a complex, multistep biological process, involving a multitude of genes and biomolecules. Despite the successful therapeutic management of breast cancer, including surgery, chemotherapy and radiation therap...

Wpływ melatoniny i agomelatyny na parametry urodynamiczne w doświadczalnym modelu pęcherza nadaktywnego – wyniki wstępne

Wstęp: Nadaktywny pęcherz moczowy (overactive bladder; OAB) jest chorobą o złożonej patogenezie, obejmującej mechanizmy neurogenne, miogenne oraz zmienioną aktywność parakrynną urotelium. Celem naszej pracy było ocenieni...

Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)

Modern medicine successfully uses multiple immunomodulators of natural origin, that can affect biological reactions and support body’s natural defense mechanisms including antitumor activities. Among them is a group of p...

The influence of reactive oxygen species on the central nervous system

Oxidative stress can be defined as a rise of oxidative potential or decrease of antioxidant status. Oxidative stress is caused by reactive oxygen species (ROS) which are produced by one-electron reduction of oxygen in...

Download PDF file
  • EP ID EP220745
  • DOI -
  • Views 160
  • Downloads 0

How To Cite

Agnieszka Matuszewska, Marta Madej, Piotr Wiland (2016). Immunological markers of rheumatoid arthritis. Advances in Hygiene and Experimental Medicine, 70(), 251-257. https://europub.co.uk./articles/-A-220745